CNS Pharmaceuticals | Press Releases

Overview Financials & Filings Press Releases Events Corporate Governance Stock Information FAQS

Press Releases

Title

Date

26 June, 2024

CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

14 June, 2024

CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement

03 June, 2024

CNS Pharmaceuticals Announces Reverse Stock Split

20 May, 2024

CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase

16 May, 2024

CNS Pharmaceuticals Reports First Quarter 2024 Financial Results

23 April, 2024

CNS Pharmaceuticals to Present at the LSX World Congress 2024

22 April, 2024

CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity

01 April, 2024

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

There are no press releases that match the selected filters.

View More

Stay Updated

All Press Releases
All SEC Filings
End of Day Stock Data
Weekly

At least one type of alert must be selected.

An email address is required.

Your email alerts were set.

The following alerts could not be set: